Treatment Delays and Survival in Patients With Hepatocellular Carcinoma: A Multicenter Cohort Study
Treatment delays exceeding 90 days occurred in over one-fifth of patients but were not associated with significant differences in survival.
Authors
- Lisa Quirk (ORCID: https://orcid.org/0000-0001-8959-3815)
- Mohammad Jarrah (ORCID: https://orcid.org/0000-0002-2816-5689)
- Sruthi Yekkaluri (ORCID: https://orcid.org/0000-0002-6246-6135)
- Paul Jones (ORCID: https://orcid.org/0000-0003-3831-8252)
- Hannah Pitts
- Sandra Garcês (ORCID: https://orcid.org/0000-0002-1287-6048)
- Mohammed Al-Hasan
- Nicole E. Rich (ORCID: https://orcid.org/0000-0003-2740-8818)
- Adam C. Yopp (ORCID: https://orcid.org/0000-0002-5887-5315)
- Amit G. Singal
- Suaiba Syeda
- Julia Terrell
- Gloria Figueroa
Institutions
- Parkland Health & Hospital System (US)
- Southwestern Medical Center (US)
- Sylvester Comprehensive Cancer Center (US)
- Southwestern Medical Center (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- The American Journal of Gastroenterology
- Published
- 2026-01-21
- DOI
- https://doi.org/10.14309/ajg.0000000000003923
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00